BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33740841)

  • 21. Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids.
    Conrad O; Burgy M; Foppolo S; Jehl A; Thiéry A; Guihard S; Vauchelles R; Jung AC; Mourtada J; Macabre C; Ledrappier S; Chenard MP; Onea MA; Danic A; Dourlhes T; Thibault C; Schultz P; Dontenwill M; Martin S
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers.
    Hudcova K; Raudenska M; Gumulec J; Binkova H; Horakova Z; Kostrica R; Babula P; Adam V; Masarik M
    Tumour Biol; 2016 Sep; 37(9):12627-12633. PubMed ID: 27440205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.
    Kinoshita T; Hanazawa T; Nohata N; Kikkawa N; Enokida H; Yoshino H; Yamasaki T; Hidaka H; Nakagawa M; Okamoto Y; Seki N
    Oncotarget; 2012 Nov; 3(11):1386-400. PubMed ID: 23159910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Fuse M; Hanazawa T; Kikkawa N; Fujimura L; Watanabe-Takano H; Yamada Y; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Biochem Biophys Res Commun; 2012 Feb; 418(2):378-83. PubMed ID: 22266319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
    Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
    Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.
    Citron F; Armenia J; Franchin G; Polesel J; Talamini R; D'Andrea S; Sulfaro S; Croce CM; Klement W; Otasek D; Pastrello C; Tokar T; Jurisica I; French D; Bomben R; Vaccher E; Serraino D; Belletti B; Vecchione A; Barzan L; Baldassarre G
    Clin Cancer Res; 2017 Jul; 23(14):3769-3780. PubMed ID: 28174235
    [No Abstract]   [Full Text] [Related]  

  • 27. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.
    Nakanishi H; Taccioli C; Palatini J; Fernandez-Cymering C; Cui R; Kim T; Volinia S; Croce CM
    Oncogene; 2014 Feb; 33(6):702-12. PubMed ID: 23416980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Oncogenic Targets by
    Okada R; Koshizuka K; Yamada Y; Moriya S; Kikkawa N; Kinoshita T; Hanazawa T; Seki N
    Cells; 2019 Nov; 8(12):. PubMed ID: 31795200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microRNAs modulating glycolysis as non-invasive prognostic biomarkers of HNSCC.
    Avilés-Jurado FX; Muñoz C; Meler C; Flores JC; Gumà J; Benaiges E; Mora J; Camacho M; León X; Vilaseca I; Terra X
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1585-1594. PubMed ID: 32737645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma.
    Saad MA; Kuo SZ; Rahimy E; Zou AE; Korrapati A; Rahimy M; Kim E; Zheng H; Yu MA; Wang-Rodriguez J; Ongkeko WM
    Mol Cancer; 2015 Oct; 14():181. PubMed ID: 26472042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma.
    Zhuang Z; Yu P; Xie N; Wu Y; Liu H; Zhang M; Tao Y; Wang W; Yin H; Zou B; Hou J; Liu X; Li J; Huang H; Wang C
    Theranostics; 2020; 10(3):1433-1453. PubMed ID: 31938073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.
    Hsu CM; Lin PM; Wang YM; Chen ZJ; Lin SF; Yang MY
    Tumour Biol; 2012 Dec; 33(6):1933-42. PubMed ID: 22811001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
    Huang Q; Shen YJ; Hsueh CY; Guo Y; Zhang YF; Li JY; Zhou L
    BMC Cancer; 2021 Oct; 21(1):1074. PubMed ID: 34598688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset.
    Chamorro Petronacci CM; García García A; Padín Iruegas E; Rivas Mundiña B; Lorenzo Pouso AI; Pérez Sayáns M
    Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33066067
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of
    Tanaka N; Minemura C; Asai S; Kikkawa N; Kinoshita T; Oshima S; Koma A; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
    Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
    Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.